Augustine Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Buy
38,644
+305
+0.8% +$24.6K 0.61% 30
2026
Q1
$3.32M Buy
38,339
+577
+2% +$55.3K 0.75% 27
2025
Q4
$3.63M Sell
37,762
-14
-0% -$1.36K 0.72% 22
2025
Q3
$3.6M Sell
37,776
-417
-1% -$38.3K 0.72% 21
2025
Q2
$3.33M Buy
38,193
+286
+0.8% +$24.3K 0.89% 22
2025
Q1
$3.41M Buy
37,907
+1,190
+3% +$106K 1% 21
2024
Q4
$2.93M Sell
36,717
-764
-2% -$66.1K 0.77% 26
2024
Q3
$3.37M Buy
37,481
+160
+0.4% +$13.5K 1.18% 21
2024
Q2
$2.94M Buy
37,321
+170
+0.5% +$13.9K 1.13% 21
2024
Q1
$3.24M Sell
37,151
-91
-0.2% -$7.77K 1.35% 19
2023
Q4
$3.07M Sell
37,242
-846
-2% -$64.5K 1.36% 20
2023
Q3
$2.98M Buy
38,088
+1,990
+6% +$167K 1.38% 20
2023
Q2
$3.18M Sell
36,098
-157
-0.4% -$13.5K 1.47% 19
2023
Q1
$2.92M Sell
36,255
-315
-0.9% -$25.7K 1.45% 19
2022
Q4
$2.84M Sell
36,570
-562
-2% -$45.5K 1.57% 18
2022
Q3
$3M Buy
37,132
+855
+2% +$76.8K 1.97% 16
2022
Q2
$3.26M Sell
36,277
-2,699
-7% -$273K 2% 15
2022
Q1
$4.32M Buy
38,976
+260
+0.7% +$27.5K 2.17% 15
2021
Q4
$4M Buy
38,716
+499
+1% +$57.8K 1.96% 17
2021
Q3
$4.79M Sell
38,217
-697
-2% -$90.2K 2.55% 11
2021
Q2
$4.83M Sell
38,914
-2,743
-7% -$344K 2.49% 12
2021
Q1
$4.92M Sell
41,657
-253
-0.6% -$29.7K 2.59% 11
2020
Q4
$4.91M Sell
41,910
-161
-0.4% -$17.7K 2.54% 12
2020
Q3
$4.37M Sell
42,071
-1,592
-4% -$160K 2.57% 10
2020
Q2
$4M Sell
43,663
-360
-0.8% -$34.5K 2.42% 14
2020
Q1
$3.97M Buy
44,023
+3,883
+10% +$413K 2.81% 11
2019
Q4
$4.55M Buy
40,140
+727
+2% +$79.8K 2.75% 12
2019
Q3
$4.28M Sell
39,413
-653
-2% -$68.1K 2.88% 11
2019
Q2
$3.9M Sell
40,066
-2,582
-6% -$236K 2.69% 13
2019
Q1
$3.88M Sell
42,648
-3,289
-7% -$294K 2.58% 12
2018
Q4
$4.18M Buy
45,937
+1,160
+3% +$108K 2.86% 11
2018
Q3
$4.4M Sell
44,777
-185
-0.4% -$17.1K 2.44% 14
2018
Q2
$3.85M Sell
44,962
-1,095
-2% -$91.5K 2.25% 19
2018
Q1
$3.69M Buy
46,057
+23
+0% +$1.9K 2.11% 18
2017
Q4
$3.72M Buy
46,034
+1,348
+3% +$108K 2.11% 18
2017
Q3
$3.48M Buy
44,686
+167
+0.4% +$13.9K 2.22% 18
2017
Q2
$3.95M Buy
44,519
+823
+2% +$69.4K 2.46% 13
2017
Q1
$3.52M Buy
43,696
+203
+0.5% +$15.9K 2.2% 14
2016
Q4
$3.1M Buy
43,493
+2,837
+7% +$223K 2.33% 16
2016
Q3
$3.51M Sell
40,656
-99
-0.2% -$8.63K 2.58% 13
2016
Q2
$3.54M Sell
40,755
-248
-0.6% -$20.1K 2.82% 12
2016
Q1
$3.25M Sell
41,003
-2,726
-6% -$205K 2.8% 16
2015
Q4
$3.36M Buy
43,729
+592
+1% +$44.6K 2.6% 17
2015
Q3
$2.89M Buy
43,137
+167
+0.4% +$12.3K 2.21% 20
2015
Q2
$3.18M Buy
42,970
+39
+0.1% +$2.98K 2.38% 19
2015
Q1
$3.31M Buy
+42,931
New +$3.25M 2.33% 19

Other funds holding MDT

Augustine Asset Management's MDT Position: Q2 2026 in Review

Augustine Asset Management increased its Medtronic (MDT) stake by 0.8% in Q2 2026, buying an estimated $24.6K and bringing the position to 38,644 shares worth $3.02M. The position accounts for 0.61% of the portfolio, ranked #30.

Augustine Asset Management first reported a position in MDT in Q1 2015 and has held it in 46 quarters since. The position peaked at $4.92M in Q1 2021. 535 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Augustine Asset Management held 38,644 shares of Medtronic worth $3.02M as of Q2 2026.
  • Augustine Asset Management bought 305 Medtronic shares in Q2 2026, an estimated $24.6K.
  • Medtronic made up 0.61% of Augustine Asset Management's portfolio in Q2 2026, its #30 holding.
  • Augustine Asset Management first reported a position in Medtronic in Q1 2015 and has held it in 46 quarters since.
  • Augustine Asset Management's Medtronic position peaked at $4.92M in Q1 2021.
  • 535 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Augustine Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.